April 6, 2011 – A pooled analysis of the SPIRIT II, III, IV and COMPARE trials further reinforces the positive clinical performance of an everolimus eluting coronary stent system.
April 5, 2011 – A microcatheter system has received the CE mark. The Plato Microcath system, by Scientia Vascular, is now available in Europe for neuro, cardio and peripheral endovascular applications.
April 5, 2011 – Uterine fibroid embolization—an interventional radiology treatment for noncancerous growths that develop in the muscular wall of the uterus—improves a number of women's lower urinary tract problems that are specifically caused by those fibroids. The finding was announced by researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 5, 2011 – Death rates are similar at one year for a catheter-based aortic valve replacement procedure and conventional surgery in older high-risk patients.
April 4, 2011 – Reducing cardiovascular risk factors such as high blood pressure, smoking, diabetes and being overweight could potentially reduce more than half of all cases of atrial fibrillation, according to research reported in Circulation: Journal of the American Heart Association.
April 4, 2011 – The U.S. Food and Drug Administration (FDA) has approved a 210-patient investigation devices exemption (IDE) clinical trial to test the efficacy of a bone marrow stem cell technology in patients with non-reconstructable critical limb ischemia (CLI).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 4, 2011 – An updated software release for a cardiovascular information system (CVIS) has now consolidated everything into a single database, including hemodynamics. The 12.2 release of McKesson’s Horizon Cardiology presents the entire patient history, from fetal to adulthood.
April 4, 2011 – Doctors are encouraged to consider therapies in addition to blood thinners to treat certain patients with potentially dangerous blood clots that form in the deep veins and travel to the lungs, according to a new scientific statement from the American Heart Association. The statement is published online in Circulation: Journal of the American Heart Association.
April 4, 2011 – Despite the high costs and heavy demand for health services associated with atrial fibrillation (AFib), a new report suggests that states may not be providing residents with the necessary resources to address and manage this common chronic disease.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
April 4, 2011 – A wireless remote monitoring program for patients with congestive heart failure (CHF) has been launched by Anthem Blue Cross. The program is designed to help patients better monitor and manage the condition.
April 4, 2011 – A unique formulation of antioxidants taken orally before imaging with ionizing radiation minimizes cell damage, noted researchers at the Society of Interventional Radiology’s 36th Annual Scientific Meeting in Chicago.
April 4, 2011 – A non-invasive cardiac test will be on display at the Scientific Sessions and Expo of the American College of Cardiology in New Orleans. The Multifunction CardioGram (MCG), from Premier Heart, offers completely non-invasive cardiac testing using power estimate as an aid to assist physicians in diagnosis.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
April 4, 2011 – A new system for treating mitral regurgitation (MR) has been launched in Australia. The MitraClip device, by Abbott, has received Therapeutic Goods Administration (TGA) approval and offers a new treatment option for patients.
April 1, 2011 – Oral antiplatelet therapy Effient (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients undergoing percutaneous coronary intervention (PCI) after experiencing heart-related chest pain at rest (unstable angina) or non-ST segment elevation myocardial infarction (NSTEMI).
April 1, 2011 –Results from the RADAR Phase 2b clinical trial will be announced at the i2 Summit during the American College of Cardiology (ACC) 2011 Annual Scientific Session and Expo. The trial examined the Reg1 anticoagulation system, from Regado Biosciences. Data will be presented by Thomas J. Povsic, M.D., Ph.D., assistant professor of medicine at Duke University.